A Prospective Study of the Separate Predictive Capabilities of 18[f]-FDG-Pet and Molecular Response in Patients With Relapsed Indolent Non-Hodgkin's Lymphoma Following Treatment With Iodine-131-Rituximab Radio-Immunotherapy
Haematologica - Italy
doi 10.3324/haematol.12253
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2008
Authors
Publisher
Ferrata Storti Foundation (Haematologica)